Skip to main content

Tardive Dyskinesia News

News
01/11/2022
Analysis of safety data for deutetrabenazine suggests the drug is generally safe and well-tolerated in both tardive dyskinesia and chorea associated with Huntington's disease patient populations.
Analysis of safety data for deutetrabenazine suggests the drug is generally safe and well-tolerated in both tardive dyskinesia and chorea associated with Huntington's disease patient populations.
Analysis of safety data for...
01/11/2022
Psych Congress Network